You can buy or sell Cortexyme and other stocks, options, and ETFs commission-free!
Cortexyme, Inc. Common Stock, also called Cortexyme, is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other neurodegenerative disorders. Its product, COR388, is in clinical trial. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA. The listed name for CRTX is Cortexyme, Inc. Common Stock.
Casey Crawford Lynch
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Mar 16, After Hours